Clinical trials
Phase 3 Atherosclerosis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 5 |
| Recruiting | 5 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Amgen | 2 |
| AstraZeneca | 2 |
| Eli Lilly and Company | 2 |
| GlaxoSmithKline | 2 |
| NewAmsterdam Pharma | 2 |
| China National Center for Cardiovascular Diseases | 1 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 1 |
| Sanofi | 1 |
| Wenzhou Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 18 |
| Cardiovascular Diseases | 4 |
| Dyslipidemias | 3 |
| Hypercholesterolemia | 3 |
| Coronary Disease | 2 |
| Heart Diseases | 2 |
| Acute Coronary Syndrome | 1 |
| Hyperlipidemias | 1 |
| Hyperlipoproteinemia Type II | 1 |
| Myocardial Infarction | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.